Pituitary adenoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
The transsphenoidal microsugrical approach is the mainstay of treatment for | The transsphenoidal microsugrical approach is the mainstay of treatment for [[growth hormone]]-(GH) producing, [[adrenocorticotropic]] hormone-(ACTH) producing, and endocrine-inactive adenomas. | ||
==Surgery== | ==Surgery== | ||
Surgical treatment and surgical contraindication for pituitary adenoma:<ref name=national cancer institute> Pituitary Tumor (2015) http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_13. Accessed on 9 28 2015 </ref> | Surgical treatment and surgical contraindication for pituitary adenoma:<ref name=national cancer institute> Pituitary Tumor (2015) http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_13. Accessed on 9 28 2015 </ref> | ||
Revision as of 15:22, 28 September 2015
|
Pituitary adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pituitary adenoma surgery On the Web |
|
American Roentgen Ray Society Images of Pituitary adenoma surgery |
|
Risk calculators and risk factors for Pituitary adenoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The transsphenoidal microsugrical approach is the mainstay of treatment for growth hormone-(GH) producing, adrenocorticotropic hormone-(ACTH) producing, and endocrine-inactive adenomas.
Surgery
Surgical treatment and surgical contraindication for pituitary adenoma:
- The transsphenoidal microsurgical approach to a pituitary lesion is the most widely employed surgical approach to pituitary lesions and represents a major development in the safe surgical treatment of both hormonally active and nonfunctioning tumors.
- This approach is often successful in debulking tumors, even those that have a significant suprasellar extension.
- A contraindication to this approach includes tumors with a significant suprasellar extension with an hourglass-shaped narrowing between the intrasellar and suprasellar component because blind attempts to reach the suprasellar tumor may lead to cerebral damage.
- An infection in the sphenoid sinus is potentially a contraindication to the transsphenoidal approach